Progress of Nimotuzumab Application in Nasopharyngeal Carcinoma

Progress of Nimotuzumab Application in Nasopharyngeal Carcinoma

Compared with the global average, the incidence rate of nasopharyngeal carcinoma (NPC) in China is higher, particularly in the southern regions where the mortality rate has remained persistently high. Nimotuzumab, a targeted therapy that acts on the epidermal growth factor receptor, has prompted con...

Full description

Saved in:
Bibliographic Details
Main Authors: Tianci LIANG, Yue ZHAO, Chenchen SONG, Chaoyi ZHANG, Chen CHEN, Qiaoran LI, Biaoxue RONG
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2024-11-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
nasopharyngeal carcinoma
nimotuzumab
epidermal growth factor receptor
targeted therapy
antitumor treatment
Online Access:http://www.zlfzyj.com/cn/article/doi/10.3971/j.issn.1000-8578.2024.24.0362
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items